are glp-1 safe weight-loss drugs for older adults? America's Poison Centers - GLP-1
Description
The SOUL trial (2025), a large-scale, double-blind, placebo-controlled study, evaluated once-daily oral semaglutide in 9,650 patients with T2DM and established atherosclerotic cardiovascular disease, chronic kidney disease, or both
Its important to know that compounded GLP-1 medications arent FDA-approved, and the FDA hasnt reviewed them for safety, quality, or how well they work
Differences in body mass index among individuals with PsA, psoriasis, RA and the general population
Waser B, Blank A, Karamitopoulou E, Perren A, Reubi JC
May 4, 2026: Next-Gen GLP-1 Leads to 16% More Weight Loss
If you have type 2 diabetes and are prescribed Ozempic or Mounjaro for blood sugar management, your Part D plan may already cover those medications through standard diabetes coverage
